Results 141 to 150 of about 4,450 (159)
[Expression of NFAT5 and IGF1R in nasopharyngeal carcinoma tissues and analysis of clinical characteristics]. [PDF]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za ZhiYang J +6 more
europepmc +1 more source
[Progress in the Study of Mechanisms Clinically Relevant to Insulin Resistance and Lung Cancer]. [PDF]
Zhongguo Fei Ai Za ZhiChen X, Chen P.
europepmc +1 more source
Research progress on bioactive peptides in the treatment of oral diseases. [PDF]
Zhong Nan Da Xue Xue Bao Yi Xue BanHuang W, Wang Y, Wang X, Li K.
europepmc +1 more source
[Silencing DDX17 inhibits proliferation and migration of pulmonary arterial smooth muscle cells <i>in vitro</i> by decreasing mTORC1 activity]. [PDF]
Nan Fang Yi Ke Da Xue Xue BaoDeng X +6 more
europepmc +1 more source
[Open experiment: quantitative proteomics analysis of thyroid-cancer tissue slices using ultra-high performance liquid chromatography-tandem mass spectrometry]. [PDF]
Se PuLi YL +5 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Medical Research and Practice, 2023
目的 探讨中晚期胰腺癌患者接受高强度聚集超声（HIFU）+化疗方案治疗价值。方法：综述国内外中晚期胰腺癌患者接受HIFU+ 化疗方案治疗文献。结果 HIFU+化疗方案治疗中晚期胰腺癌，可减轻胰腺癌患者病痛，同时可延长胰腺癌生存期，且胰腺癌整体并发症风险低。结论 中晚期胰腺癌患者接受HIFU+化疗方案治疗期间，能够强化化疗效果，控制胰腺癌疾病进展，过程无创、安全，不加重并发症等优势已渐渐成为胰腺癌综合的重要手段，期待在未来会有更多HIFU联合化疗针对胰腺癌的运用，在患者获益的同时进行更深层次的探索和研究。
志强 谢, 涯昆 吴
semanticscholar +1 more source
目的 探讨中晚期胰腺癌患者接受高强度聚集超声（HIFU）+化疗方案治疗价值。方法：综述国内外中晚期胰腺癌患者接受HIFU+ 化疗方案治疗文献。结果 HIFU+化疗方案治疗中晚期胰腺癌，可减轻胰腺癌患者病痛，同时可延长胰腺癌生存期，且胰腺癌整体并发症风险低。结论 中晚期胰腺癌患者接受HIFU+化疗方案治疗期间，能够强化化疗效果，控制胰腺癌疾病进展，过程无创、安全，不加重并发症等优势已渐渐成为胰腺癌综合的重要手段，期待在未来会有更多HIFU联合化疗针对胰腺癌的运用，在患者获益的同时进行更深层次的探索和研究。
志强 谢, 涯昆 吴
semanticscholar +1 more source